Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology (Oxford, England) England), 2022-05, Vol.61 (5), p.e109-e111
Hauptverfasser:	Ramirez, Giuseppe A, Lanzillotta, Marco, Ebbo, Mikael, Fernandez-Codina, Andreu, Mancuso, Gaia, Orozco-Galvez, Olimpia, Dagna, Lorenzo, Schleinitz, Nicolas, Martínez-Valle, Fernando, Culver, Emma L, Della-Torre, Emanuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Autoimmune Diseases COVID-19 Humans Immunoglobulin G Immunoglobulin G4-Related Disease - complications Immunoglobulin G4-Related Disease - diagnosis Immunoglobulin G4-Related Disease - drug therapy Published Online Only Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e111
container_issue	5
container_start_page	e109
container_title	Rheumatology (Oxford, England)
container_volume	61
creator	Ramirez, Giuseppe A Lanzillotta, Marco Ebbo, Mikael Fernandez-Codina, Andreu Mancuso, Gaia Orozco-Galvez, Olimpia Dagna, Lorenzo Schleinitz, Nicolas Martínez-Valle, Fernando Culver, Emma L Della-Torre, Emanuel
description
doi_str_mv	10.1093/rheumatology/keab930
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9383139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/rheumatology/keab930</oup_id><sourcerecordid>2611665513</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-f3e2c40a7b8853573f0745e8d2d4533678f9df5f23676997d957099f403067d63</originalsourceid><addsrcrecordid>eNqNUU1vEzEQtSpQWwr_oEI-cllir70f7gEJpaVEqtQLcLWc9Thx8a63_miVf48hISo3TvNG896b0TyELin5SIlgi7CFPKrknd_sFj9BrQUjJ-ic8rauCGP1qyOu-Rl6E-MDIaShrD9FZ4wLKtq2OUd-6exkB-WwAZVygIjVpLHPafBjabzBy_sfq-uKCmwnPKtkYUoRP9u0xavNLa8COJVAY20jqAhXWOGbHPwMasJjdslWQ1EEwDFlvXuLXhvlIrw71Av0_cvNt-XX6u7-drX8fFcNnPepMgzqgRPVrfu-YU3HDOl4A72uNW8Ya7veCG0aUxfYCtFp0XRECMMJI22nW3aBPu1957weQf85QTk5BzuqsJNeWfnvZLJbufFPUrCeUSaKwYeDQfCPGWKSo40DOKcm8DnKuqW0fLA8tFD5njoEH2MAc1xDifydlXyZlTxkVWTvX554FP0NpxAWe4LP8_9Z_gIuXqZL</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2611665513</pqid></control><display><type>article</type><title>Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Ramirez, Giuseppe A ; Lanzillotta, Marco ; Ebbo, Mikael ; Fernandez-Codina, Andreu ; Mancuso, Gaia ; Orozco-Galvez, Olimpia ; Dagna, Lorenzo ; Schleinitz, Nicolas ; Martínez-Valle, Fernando ; Culver, Emma L ; Della-Torre, Emanuel</creator><creatorcontrib>Ramirez, Giuseppe A ; Lanzillotta, Marco ; Ebbo, Mikael ; Fernandez-Codina, Andreu ; Mancuso, Gaia ; Orozco-Galvez, Olimpia ; Dagna, Lorenzo ; Schleinitz, Nicolas ; Martínez-Valle, Fernando ; Culver, Emma L ; Della-Torre, Emanuel</creatorcontrib><identifier>ISSN: 1462-0324</identifier><identifier>EISSN: 1462-0332</identifier><identifier>DOI: 10.1093/rheumatology/keab930</identifier><identifier>PMID: 34919665</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Autoimmune Diseases ; COVID-19 ; Humans ; Immunoglobulin G ; Immunoglobulin G4-Related Disease - complications ; Immunoglobulin G4-Related Disease - diagnosis ; Immunoglobulin G4-Related Disease - drug therapy ; Published Online Only ; Retrospective Studies</subject><ispartof>Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.e109-e111</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-f3e2c40a7b8853573f0745e8d2d4533678f9df5f23676997d957099f403067d63</citedby><cites>FETCH-LOGICAL-c448t-f3e2c40a7b8853573f0745e8d2d4533678f9df5f23676997d957099f403067d63</cites><orcidid>0000-0002-2889-366X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1584,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34919665$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramirez, Giuseppe A</creatorcontrib><creatorcontrib>Lanzillotta, Marco</creatorcontrib><creatorcontrib>Ebbo, Mikael</creatorcontrib><creatorcontrib>Fernandez-Codina, Andreu</creatorcontrib><creatorcontrib>Mancuso, Gaia</creatorcontrib><creatorcontrib>Orozco-Galvez, Olimpia</creatorcontrib><creatorcontrib>Dagna, Lorenzo</creatorcontrib><creatorcontrib>Schleinitz, Nicolas</creatorcontrib><creatorcontrib>Martínez-Valle, Fernando</creatorcontrib><creatorcontrib>Culver, Emma L</creatorcontrib><creatorcontrib>Della-Torre, Emanuel</creatorcontrib><title>Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study</title><title>Rheumatology (Oxford, England)</title><addtitle>Rheumatology (Oxford)</addtitle><subject>Autoimmune Diseases</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin G4-Related Disease - complications</subject><subject>Immunoglobulin G4-Related Disease - diagnosis</subject><subject>Immunoglobulin G4-Related Disease - drug therapy</subject><subject>Published Online Only</subject><subject>Retrospective Studies</subject><issn>1462-0324</issn><issn>1462-0332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUU1vEzEQtSpQWwr_oEI-cllir70f7gEJpaVEqtQLcLWc9Thx8a63_miVf48hISo3TvNG896b0TyELin5SIlgi7CFPKrknd_sFj9BrQUjJ-ic8rauCGP1qyOu-Rl6E-MDIaShrD9FZ4wLKtq2OUd-6exkB-WwAZVygIjVpLHPafBjabzBy_sfq-uKCmwnPKtkYUoRP9u0xavNLa8COJVAY20jqAhXWOGbHPwMasJjdslWQ1EEwDFlvXuLXhvlIrw71Av0_cvNt-XX6u7-drX8fFcNnPepMgzqgRPVrfu-YU3HDOl4A72uNW8Ya7veCG0aUxfYCtFp0XRECMMJI22nW3aBPu1957weQf85QTk5BzuqsJNeWfnvZLJbufFPUrCeUSaKwYeDQfCPGWKSo40DOKcm8DnKuqW0fLA8tFD5njoEH2MAc1xDifydlXyZlTxkVWTvX554FP0NpxAWe4LP8_9Z_gIuXqZL</recordid><startdate>20220505</startdate><enddate>20220505</enddate><creator>Ramirez, Giuseppe A</creator><creator>Lanzillotta, Marco</creator><creator>Ebbo, Mikael</creator><creator>Fernandez-Codina, Andreu</creator><creator>Mancuso, Gaia</creator><creator>Orozco-Galvez, Olimpia</creator><creator>Dagna, Lorenzo</creator><creator>Schleinitz, Nicolas</creator><creator>Martínez-Valle, Fernando</creator><creator>Culver, Emma L</creator><creator>Della-Torre, Emanuel</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2889-366X</orcidid></search><sort><creationdate>20220505</creationdate><title>Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study</title><author>Ramirez, Giuseppe A ; Lanzillotta, Marco ; Ebbo, Mikael ; Fernandez-Codina, Andreu ; Mancuso, Gaia ; Orozco-Galvez, Olimpia ; Dagna, Lorenzo ; Schleinitz, Nicolas ; Martínez-Valle, Fernando ; Culver, Emma L ; Della-Torre, Emanuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-f3e2c40a7b8853573f0745e8d2d4533678f9df5f23676997d957099f403067d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Autoimmune Diseases</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin G4-Related Disease - complications</topic><topic>Immunoglobulin G4-Related Disease - diagnosis</topic><topic>Immunoglobulin G4-Related Disease - drug therapy</topic><topic>Published Online Only</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramirez, Giuseppe A</creatorcontrib><creatorcontrib>Lanzillotta, Marco</creatorcontrib><creatorcontrib>Ebbo, Mikael</creatorcontrib><creatorcontrib>Fernandez-Codina, Andreu</creatorcontrib><creatorcontrib>Mancuso, Gaia</creatorcontrib><creatorcontrib>Orozco-Galvez, Olimpia</creatorcontrib><creatorcontrib>Dagna, Lorenzo</creatorcontrib><creatorcontrib>Schleinitz, Nicolas</creatorcontrib><creatorcontrib>Martínez-Valle, Fernando</creatorcontrib><creatorcontrib>Culver, Emma L</creatorcontrib><creatorcontrib>Della-Torre, Emanuel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Rheumatology (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramirez, Giuseppe A</au><au>Lanzillotta, Marco</au><au>Ebbo, Mikael</au><au>Fernandez-Codina, Andreu</au><au>Mancuso, Gaia</au><au>Orozco-Galvez, Olimpia</au><au>Dagna, Lorenzo</au><au>Schleinitz, Nicolas</au><au>Martínez-Valle, Fernando</au><au>Culver, Emma L</au><au>Della-Torre, Emanuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study</atitle><jtitle>Rheumatology (Oxford, England)</jtitle><addtitle>Rheumatology (Oxford)</addtitle><date>2022-05-05</date><risdate>2022</risdate><volume>61</volume><issue>5</issue><spage>e109</spage><epage>e111</epage><pages>e109-e111</pages><issn>1462-0324</issn><eissn>1462-0332</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>34919665</pmid><doi>10.1093/rheumatology/keab930</doi><orcidid>https://orcid.org/0000-0002-2889-366X</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1462-0324
ispartof	Rheumatology (Oxford, England), 2022-05, Vol.61 (5), p.e109-e111
issn	1462-0324 1462-0332
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9383139
source	MEDLINE; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects	Autoimmune Diseases COVID-19 Humans Immunoglobulin G Immunoglobulin G4-Related Disease - complications Immunoglobulin G4-Related Disease - diagnosis Immunoglobulin G4-Related Disease - drug therapy Published Online Only Retrospective Studies
title	Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T01%3A18%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20and%20outcomes%20of%20COVID-19%20in%20patients%20with%20IgG4-related%20disease:%20a%20European%20multi-centre%20study&rft.jtitle=Rheumatology%20(Oxford,%20England)&rft.au=Ramirez,%20Giuseppe%20A&rft.date=2022-05-05&rft.volume=61&rft.issue=5&rft.spage=e109&rft.epage=e111&rft.pages=e109-e111&rft.issn=1462-0324&rft.eissn=1462-0332&rft_id=info:doi/10.1093/rheumatology/keab930&rft_dat=%3Cproquest_pubme%3E2611665513%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2611665513&rft_id=info:pmid/34919665&rft_oup_id=10.1093/rheumatology/keab930&rfr_iscdi=true